Over the course of a 2 day expert workshop held on the topic of cancer and anaesthesia at the College of Anaesthetists of Ireland in Dublin, Ireland, the following consensus statement was developed by delegates to this unique BJA workshop (see online BJA open access supplement July 2014). This followed from their presentations of their own ongoing cutting edge research in this area and intensive interactive discussions around the existing literature and the priorities for future research. Initial brainstorming sessions resulted in a list of statements under various categories that was progressively distilled to the following concise summary after extensive inclusive discussion. We urge national and international research funding bodies to take note of these recommendations, particularly in terms of funding large-scale prospective, randomized, blinded clinical trials that can most effectively address the important clinical questions raised. We also urge the anaesthesia and cancer research communities to comment by corresponding with the BJA through its eLetter mechanism (http://bja. oxfordjournals.org/letters/).
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(i) While the concept that anaesthetic or analgesic technique might affect cancer outcomes is intriguing, there is currently insufficient evidence to support any change in clinical practice. (ii) Available data on the role of opioids in cancer are conflicting, possibly due to the use of different experimental models. Long-term opioid administration in subanalgesic doses in mice without surgery suggests that morphine promotes cancer growth. In contrast, mouse models resembling the perioperative setting, using analgesic doses of opioid, suggest either a protective effect of opioids for cancer or no effect. (iii) Morphine does not appear to stimulate tumour initiation, and there is currently no evidence that morphine analgesia causes cancer. Whether opioid administration augments the risk of recurrence or metastasis after cancer surgery remains unclear. 
